DrugDashboards

Sodium Chloride

Sodium Chloride · SODIUM CHLORIDE 9 mg/mL · Injection, Solution · Intramuscular; Intravenous; Subcutaneous · Hospira, Inc.

NDC 00409-4888-20 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 20 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. The price is up 13% over the past year, to $0.0584 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0584per MLinvoice-surveyed acquisition cost · May 22, 2024
  • Part D plans paid (avg)$0.1274per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04$0.06Nov 2014May 2024$0.0584
3 price points · per ML · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$59.94
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1.2M
3,484 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

18Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • Class I/II recall on same molecule/form in past 12 months+8
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

1.5%chance of a new FDA shortage posting for sodium chloride (injectable) in the next 90 days

sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 10× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $16.68 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA018803
TE code
AP
Approval date
Oct 29, 1982
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67)Dec 3, 2025
  • Planned discontinuation Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02)Dec 3, 2025

Recalls (this NDC)

  • Class II · TerminatedJun 27, 2013
    Hospira Inc.Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.

Manufacturers of Sodium Chloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
B. Braun Medical Inc.SODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
ICU Medical Inc.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Spectra Medical Deviecs, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 4.5 g/1000mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE .9 g/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanySODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson And CompanySODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Codan Us CorporationSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 2250 mg/500mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 234 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 3 g/100mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 225 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 1125 mg/250mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Laboratorios Grifols SaSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Medefil, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Nextgen Pharmaceuticals LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
ProPharma DistributionSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Sportpharm LLCSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 9 g/1000mLJul 15, 2026Aug 31, 2026
ICU Medical Inc.SODIUM CHLORIDE 450 mg/100mLJul 15, 2026Aug 31, 2026
ProPharma DistributionSODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 31, 2026
Henry Schein, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 29, 2026
B. Braun Medical Inc.SODIUM CHLORIDE .45 g/100mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Chloride — NDC 00409-4888-20," retrieved September 3, 2026, https://drugdashboards.com/drug/00409488820.

Free to cite with attribution — see how the data is put together.